Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbial Transplantation in Crohn's Disease
NCT03267238Phase 1Completed
- Sponsor
- Stony Brook University
- Start
- Jun 2017
- Primary completion
- Feb 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of allogeneic fecal microbiota in Crohn's disease, sponsored by Stony Brook University. Primary endpoint: Number of participants with treatment-related adverse events at 5 years. Started Jun 2017; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03267238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03267238.